ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Lacticaseibacillus Rhamnosus R1039

Also known as: Lacticaseibacillus rhamnosus R1039, L. rhamnosus R1039

Overview

Lacticaseibacillus rhamnosus R1039 is a strain of probiotic bacteria known for its potential health benefits, particularly in improving gut flora. Probiotics, in general, are live microorganisms that, when consumed, can enhance gastrointestinal health and support immune function. While research on L. rhamnosus R1039 is limited compared to more extensively studied strains like L. rhamnosus GG, it is believed to share similar properties. These include the ability to colonize the gut, enhance the intestinal barrier function, and modulate the immune system. Probiotics like L. rhamnosus R1039 are available in various forms, including capsules and powders, and are typically taken orally. They are sourced through fermentation processes and are often included in dietary supplements and functional foods. Further research is needed to fully elucidate the specific benefits and mechanisms of action of L. rhamnosus R1039.

Benefits

Specific benefits of Lacticaseibacillus rhamnosus R1039 are not well-documented in peer-reviewed literature. However, L. rhamnosus strains, including the well-studied L. rhamnosus GG, are generally known for their potential to improve gut health and reduce symptoms of gastrointestinal disorders. L. rhamnosus GG has demonstrated efficacy in reducing antibiotic-associated diarrhea and potentially treating acute gastroenteritis in children. Given the similarities between L. rhamnosus strains, L. rhamnosus R1039 may offer similar benefits, but further research is needed to confirm this. The strength of evidence for these benefits in the context of L. rhamnosus R1039 is currently low due to the lack of specific studies.

How it works

Lacticaseibacillus rhamnosus R1039, like other probiotics, is believed to exert its effects by colonizing the gut and enhancing the barrier function of the intestinal lining. This colonization helps to prevent the adhesion and proliferation of pathogenic bacteria. Additionally, it modulates the immune system by interacting with immune cells in the gut-associated lymphoid tissue (GALT). The bacteria can also produce antimicrobial substances, such as bacteriocins, which inhibit the growth of harmful bacteria. These combined actions contribute to a healthier gut microbiome and improved overall gastrointestinal function.

Side effects

Probiotics, including Lacticaseibacillus rhamnosus R1039, are generally considered safe for most individuals. Common side effects are typically mild and may include gastrointestinal symptoms such as bloating, gas, or mild abdominal discomfort. These symptoms are usually transient and resolve on their own. However, in rare cases, particularly in immunocompromised individuals, there is a risk of more serious side effects such as systemic infections. It is advisable for individuals with weakened immune systems, such as those with HIV/AIDS or undergoing chemotherapy, to consult with a healthcare provider before taking probiotic supplements. There are no specific drug interactions documented for L. rhamnosus R1039, but it is always prudent to inform healthcare providers about all supplements being taken.

Dosage

Dosing guidelines for Lacticaseibacillus rhamnosus R1039 are not explicitly established in the scientific literature. However, based on the dosing recommendations for other L. rhamnosus strains, such as L. rhamnosus GG, a typical dosage range is between 1 x 10^9 to 1 x 10^10 CFU (colony-forming units) per day. The appropriate dosage may vary depending on the individual's health status, the specific product formulation, and the intended use. Probiotics are typically taken orally, and the timing of administration (with or without food) may vary depending on the specific product. It is important to follow the manufacturer's instructions and consult with a healthcare provider for personalized recommendations.

FAQs

How should I take L. rhamnosus R1039?

Typically taken orally in capsule or powder form. Follow product instructions. Consistency is key for best results.

Is L. rhamnosus R1039 safe?

Generally safe for most. Consult a healthcare provider if you are immunocompromised or have underlying health conditions.

When is the best time to take L. rhamnosus R1039?

Can be taken with or without food. Some prefer taking it with a meal to minimize potential gastrointestinal discomfort.

What results can I expect from taking L. rhamnosus R1039?

Results may vary. Generally, improvements in gut health and digestive comfort are expected with consistent use.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/26365389/ – This meta-analysis investigated the efficacy of probiotics for the prevention of antibiotic-associated diarrhea (AAD). The study found that certain probiotic strains, including L. rhamnosus GG, were effective in reducing the risk of AAD, highlighting the potential of probiotics in managing gastrointestinal health during antibiotic treatment.
  • https://pubmed.ncbi.nlm.nih.gov/31025399/ – This systematic review and meta-analysis assessed the effectiveness of probiotics in treating acute gastroenteritis in children. The findings indicated that L. rhamnosus GG could reduce the duration of diarrhea and the length of hospital stay, suggesting a beneficial role in managing acute gastroenteritis in pediatric populations.
  • https://tp.amegroups.org/article/view/128126/html – This review discusses the role of probiotics in preventing and treating various gastrointestinal disorders. It highlights the mechanisms by which probiotics, including L. rhamnosus strains, can modulate the gut microbiota and immune responses, contributing to improved gut health and reduced inflammation.
  • https://www.mdpi.com/2076-2607/11/11/2804 – This study investigates the impact of L. rhamnosus on gut microbiota composition and metabolic activity. The research suggests that L. rhamnosus can promote a more balanced gut environment, potentially improving digestive health and overall well-being through its influence on microbial communities.
  • https://pubmed.ncbi.nlm.nih.gov/35840226/ – This study explores the effects of L. rhamnosus on immune function and inflammatory responses. The findings indicate that L. rhamnosus can modulate immune cell activity and reduce pro-inflammatory cytokine production, suggesting a potential role in managing inflammatory conditions and supporting immune health.